Shed Some Light on DED: New IPL technology can help you meet the needs of this growing patient population.

The article offers information on the intense pulsed light (IPL) therapy for meibomian gland dysfunction (MGD) treatment. Topics discussed include second iteration with the advent of low-level light therapy (LLLT), a new two-step approach; Activation of fibroblasts and enhancing the synthesis of new collagen fibers by IPL; and also mentions about combined treatment of the Ocular Surface Disease Index (OSDI).